Etheno-adduct-forming chemicals: From mutagenicity testing to tumor mutation spectra

Mutation Research - Reviews in Mutation Research

Volumn 462, Issue 2-3, 2000, Pages 55-69

  Barbin, Alain ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Etheno adducts; Lipid peroxidation; Tumor mutation spectra; Urethane; Vinyl chloride

Indexed keywords

URETHAN; VINYL CHLORIDE;

ANGIOSARCOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; CARCINOGENESIS; CONTROLLED STUDY; GENOTOXICITY; HUMAN; LIPID PEROXIDATION; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLIC ACTIVATION; MOUSE; MUTAGEN TESTING; MUTAGENICITY; MUTATION; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RAT; REVIEW; SITE DIRECTED MUTAGENESIS;

RODENTIA;

EID: 0034031990     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(00)00014-4     Document Type: Article

References (119)

1. Creech J.L. Jr., Johnson M.N. Angiosarcoma of liver in the manufacture of polyvinyl chloride. J. Occup. Med. 16:1974;150-151.
2. Maltoni C., Lefemine G., Chieco P., Caretti D. Vinyl chloride carcinogenesis: current results and perspectives. Med. Lav. 65:1974;421-444.
3. Bartsch H., Malaveille C., Barbin A., Brésil H., Tomatis L., Montesano R. Mutagenicity and metabolism of vinyl chloride and related compounds. Environ. Health Perspect. 17:1976;193-198.
4. Giri A.K. Genetic toxicology of vinyl chloride - a review. Mutat. Res. 339:1995;1-14.
5. Malaveille C., Bartsch H., Barbin A., Camus A.-M., Montesano R., Croisy A., Jacquignon P. Mutagenicity of vinyl chloride, chloroethylene oxide, chloroacetaldehyde and chloroethanol. Biochem. Biophys. Res. Commun. 63:1975;363-370.
6. Barbin A., Brésil H., Croisy A., Jacquignon P., Malaveille C., Montesano R., Bartsch H. Liver-microsome-mediated formation of alkylating agents from vinyl bromide and vinyl chloride. Biochem. Biophys. Res. Commun. 67:1975;596-603.
7. 4-ethenocytosine, DNA reaction products of vinyl chloride metabolites, during in vitro DNA synthesis. Nucleic Acids Res. 9:1981;375-387.
8. Hall J.A., Saffhill R., Green T., Hathway D.E. The induction of errors during in vitro DNA synthesis following chloroacetaldehyde treatment of poly(dA-dT) and poly(dC-dG) templates. Carcinogenesis. 2:1981;141-146.
9. 4-ethenocytidine in polyribonucleotides. Nucleic Acids Res. 9:1981;365-373.
10. 4-etheno-2′-deoxycytidine detected by monoclonal antibodies in lung and liver DNA of rats exposed to vinyl chloride. Carcinogenesis. 10:1989;209-212.
11. 2,3-ethenoguanine based on electrophore labeling. Carcinogenesis. 11:1990;1279-1285.
12. 4-ethenocytosine in DNA, in: D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.), Postlabeling Methods for Detection of DNA Adducts, Vol. 124, IARC Sci. Publ., IARC, Lyon, 1993, pp. 263-269.
13. Bartsch H., Barbin A., Marion M.J., Nair J., Guichard Y. Formation, detection, and role in carcinogenesis of ethenobases in DNA. Drug Metab. Rev. 26:1994;349-371.
14. Nair J., Barbin A., Velic I., Bartsch H. Etheno DNA-base adducts from endogenous reactive species. Mutat. Res. 424:1999;59-69.
15. Wiseman R.W., Stowers S.J., Miller E.C., Anderson M.W., Miller J.A. Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3F1 mouse. Proc. Natl. Acad. Sci. U.S.A. 83:1986;5825-5829.
16. Marion M.-J., Froment O., Trépo C. Activation of Ki-ras gene by point mutation in human liver angiosarcoma associated with vinyl chloride exposure. Mol. Carcinogen. 4:1991;450-454.
17. Hollstein M., Marion M.-J., Lehman T., Welsh J., Harris C.C., Martel-Planche G., Kusters I., Montesano R. p53 mutations at A:T base pairs in angiosarcomas of vinyl-chloride-exposed factory workers. Carcinogenesis. 15:1994;1-3.
18. Kochetkov N.K., Shibaev V.N., Kost A.A. New reaction of adenine and cytosine derivatives, potentially useful for nucleic acid modifications. Tetrahedron Lett. 22:1971;1993-1996.
19. IARC, in: B. Singer, H. Bartsch (Eds.), The Role of Cyclic Nucleic Acid Adducts in Carcinogenesis and Mutagenesis, Vol. 70, IARC. Sci. Publ., IARC, Lyon, 1986.
20. IARC, in: B. Singer, H. Bartsch (Eds.), Exocyclic Nucleic Acid Adducts in Mutagenesis and Carcinogenesis, Vol. 150, IARC Sci. Publ., IARC, Lyon, 1999.
21. Kronberg L., Karlsson S., Sjoholm R. Formation of ethenocarbaldehyde derivatives of adenosine and cytidine in reactions with mucochloric acid. Chem. Res. Toxicol. 6:1993;495-499.
22. 6-ethenoadenine by gas chromatography/negative ion chemical ionization/mass spectrometry. Chem. Res. Toxicol. 11:1998;1474-1480.
23. 2-ethenoguanine and 5,6,7,9-tetrahydro-7-hydroxy-9-oxoimidazo[1,2-α]purine in DNA treated with 2-chlorooxirane by high-performance liquid chromatography/electrospray mass spectrometry and comparison of amounts to other DNA adducts. Chem. Res. Toxicol. 10:1997;242-247.
24. Kusmierek J.T., Singer B. Chloroacetaldehyde-treated ribo- and deoxyribopolynucleotides: 1. Reaction products. Biochemistry. 21:1982;5717-5722.
25. Guengerich F.P., Raney V.M. Formation of etheno adducts of adenosine and cytidine from 1-halooxiranes. Evidence for a mechanism involving initial reaction with the endocyclic nitrogen atoms. J. Am. Chem. Soc. 3:1992;1074-1080.
26. Yip K.F., Tsou K.C. Synthesis of fluorescent adenosine derivatives. Tetrahedron Lett. 33:1973;3087-3090.
27. 2-ethenoguanine in Chinese hamster ovary cell chromosomal DNA. Chem. Res. Toxicol. 12:1999;501-507.
28. McCann J., Simmon V., Streitwieser D., Ames B.N. Mutagenicity of chloroacetaldehyde, a possible metabolic product of 1,2-dichloroethane (ethylene dichloride), chloroethanol (ethylene chlorohydrin), vinyl chloride, and cyclophosphamide. Proc. Natl. Acad. Sci. U.S.A. 72:1975;3190-3193.
29. Eisenstadt E., Miller J.K., Kahng L.-S., Barnes W.M. Influence of uvrB and pKM101 on the spectrum of spontaneous, UV- and γ-ray-induced base substitutions that revert hisG46 in Salmonella typhimurium. Mutat. Res. 210:1989;113-125.
30. Barbin A., Tenenbaum L., Toman Z., Radman M., Bartsch H. recA-independent mutagenicity induced by chloroethylene oxide in E. coli. Mutat. Res. 152:1985;157-159.
31. Barbin A., Besson F., Perrard M.-H., Béréziat J.-C., Kaldor J., Michel G., Bartsch H. Induction of specific base-pair substitutions in E. coli trpA mutants by chloroethylene oxide, a carcinogenic vinyl chloride metabolite. Mutat. Res. 152:1985;147-156.
32. Ballering L.A.P., Nivard M.J.M., Vogel E.W. Characterization by two-endpoint comparisons of the genetic toxicity profiles of vinyl chloride and related etheno-adduct-forming carcinogens in Drosophila. Carcinogenesis. 17:1996;1083-1092.
33. Ballering L.A.P., Nivard M.J.M., Vogel E.W. Preferential formation of deletions following in vivo exposure of postmeiotic Drosophila germ cells to the DNA etheno-adduct-forming carcinogen vinyl carbamate. Environ. Mol. Mutagen. 30:1997;321-329.
34. Chiang S.-Y., Swenberg J.A., Weisman W.H., Skopek T.R. Mutagenicity of vinyl chloride and its reactive metabolites, chloroethylene oxide and chloroacetaldehyde, in a metabolically competent human B-lymphoblastoid line. Carcinogenesis. 18:1997;31-36.
35. Liber H.L., Kaufmann W., Marion M., Swenberg J.A. Exposure to vinyl chloride is associated with a persistent increase in hprt mutants in the peripheral blood lymphocytes. Proc. Am. Assoc. Cancer Res. 40:1999;508.
36. 4-ethenocytosine, and 4-amino-5-(imidazol-2-yl)imidazole. Biochemistry. 32:1993;12793-12801.
37. 4-etheno-2′-deoxycytidine in reactions catalyzed by mammalian DNA polymerases. Biochemistry. 35:1996;14992-14998.
38. Palejwala V.A., Rzepka R.W., Simha D., Humayun M.Z. Quantitative multiplex sequence analysis of mutational hot spots. Frequency and specificity of mutations induced by a site-specific ethenocytosine in M13 viral DNA. Biochemistry. 32:1993;4105-4111.
39. Palejwala V.A., Rzepka R.W., Humayun M.Z. UV irradiation of Escherichia coli modulates mutagenesis at a site-specific ethenocytosine residue on M13 DNA. Evidence for an inducible recA-independent effect. Biochemistry. 32:1993;4112-4120.
40. Singer B., Kusmierek J.T., Fraenkel-Conrat H. In vitro discrimination of replicases acting on carcinogen-modified polynucleotide templates. Proc. Natl. Acad. Sci. U.S.A. 80:1983;969-972.
41. Jacobsen J.S., Perkins C.P., Callahan J.T., Sambamurti K., Humayun M.Z. Mechanisms of mutagenesis by chloroacetaldehyde. Genetics. 121:1989;213-222.
42. Borys E., Mroczkowska-Swpska M.M., Kusmierek J.T. The induction of adaptive response to alkylating agents in Escherichia coli reduces the frequency of specific C→T mutations in chloroacetaldehyde-treated M13 glyU phage. Mutagenesis. 9:1994;407-410.
43. -, human immunodeficiency virus-1 reverse transcriptase, and rat polymerase β Biochemistry. 36:1997;6069-6079.
44. Moriya M., Zhang W., Johnson F., Grollman A.P. Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. Proc. Natl. Acad. Sci. U.S.A. 91:1994;11899-11903.
45. 6-ethenodeoxyadenosine (εA): formation of εA base pairs and elongation in defined templates. Carcinogenesis. 18:1997;1609-1615.
46. El Ghissassi F., Barbin A., Bartsch H. Metabolic activation of vinyl chloride by rat liver microsomes: low-dose kinetics and involvement of cytochrome P450 2E1. Biochem. Pharmacol. 55:1998;1445-1452.
47. Barbin A. Formation of DNA etheno adducts in rodents and humans and their role in carcinogenesis. Acta Biochim. Pol. 45:1998;145-161.
48. R.J. Laib, The role of cyclic base adducts in vinyl-chloride-induced carcinogenesis: studies on nucleic acid alkylation in vivo, in: B. Singer, H. Bartsch (Eds.), The Role of Cyclic Nucleic Acid Adducts in Carcinogenesis and Mutagenesis, Vol. 70, IARC Sci. Publ., IARC, Lyon, 1986, pp. 101-108.
49. Green T., Hathway D.E. Interactions of vinyl chloride with rat liver DNA in vivo. Chem. Biol. Interact. 22:1978;211-224.
50. Ciroussel F., Barbin A., Eberle G., Bartsch H. Investigations on the relationship between DNA ethenobase adduct levels in several organs of vinyl-chloride-exposed rats and cancer susceptibility. Biochem. Pharmacol. 39:1990;1109-1113.
51. 2,3-ethenoguanine in rat tissue DNA. Carcinogenesis. 11:1990;1287-1292.
52. Swenberg J.A., Fedtke N., Ciroussel F., Barbin A., Bartsch H. Etheno adducts formed in DNA of vinyl-chloride-exposed rats are highly persistent in liver. Carcinogenesis. 13:1992;727-729.
53. 32P -postlabeling Carcinogenesis. 16:1995;613-617.
54. Guichard Y., El Ghissassi F., Nair J., Bartsch H., Barbin A. Formation and accumulation of DNA ethenobases in adult Sprague-Dawley rats exposed to vinyl chloride. Carcinogenesis. 17:1996;1553-1559.
55. A. Barbin, Role of etheno DNA adducts in carcinogenesis induced by vinyl chloride in rats, in: B. Singer, H. Bartsch (Eds.), Exocyclic Nucleic Acid Adducts in Mutagenesis and Carcinogenesis, Vol. 150, IARC Sci. Publ., IARC, Lyon, 1999, pp. 303-313.
56. Ranasinghe A., Scheller N., Wu K.Y., Upton P.B., Swenberg J.A. Application of gas chromatography/electron capture negative chemical ionization high-resolution mass spectrometry for analysis of DNA and protein adducts. Chem. Res. Toxicol. 11:1998;520-526.
57. J.A. Swenberg, M. Bogdanffy, A. Ham, S. Holt, A. Kim, E.J. Morinello, A. Ranasinghe, N. Scheller, P.B. Upton, Formation and repair of DNA adducts in vinyl chloride- and vinyl-fluoride-induced carcinogenesis, in: B. Singer, H. Bartsch (Eds.), Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis, Vol. 150, IARC Sci. Publ., IARC, Lyon, 1999, pp. 29-43.
58. IARC, Some anti-thyroid and related substances, nitrofurans and industrial chemicals, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 7, IARC, Lyon, 1974, pp. 1-326.
59. Zimmerli B., Schlatter J. Ethyl carbamate: analytical methodology, occurrence, formation, biological activity and risk assessment. Mutat. Res. 259:1991;325-350.
60. 6-ethenoadenosine. Chem. Res. Toxicol. 4:1991;413-421.
61. Miller J.A., Miller E.C. The metabolic activation and nucleic acid adducts of naturally occurring carcinogens: recent results with ethyl carbamate and the spice flavors safrole and estragole. Br. J. Cancer. 48:1983;1-15.
62. 3H -sodium borohydride, in: B. Singer, H. Bartsch (Eds.), The Role of Cyclic Nucleic Acid Adducts in Carcinogenesis and Mutagenesis, Vol. 70, IARC Sci. Publ., IARC, Lyon, 1986, pp. 109-125.
63. 6-Ethenoadenosine formation, mutagenicity and murine tumor induction as indicators of the generation of an electrophilic epoxide metabolite of the closely related carcinogens ethyl carbamate (urethane) and vinyl carbamate. Carcinogenesis. 11:1990;463-473.
64. 14C ] ethyl carbamate (urethan) Carcinogenesis. 3:1982;539-546.
65. Park K.K., Liem A., Stewart B.C., Miller J.A. Vinyl carbamate epoxide, a major strong electrophilic, mutagenic and carcinogenic metabolite of vinyl carbamate and ethyl carbamate (urethane). Carcinogenesis. 14:1993;441-450.
66. 32P -postlabeling in liver and lung DNA of mice treated with ethyl carbamate (urethane) or its metabolites Carcinogenesis. 17:1996;1711-1718.
67. 2-Ethenodeoxyguanosine as a potential marker for DNA adduct formation by trans-4-hydroxy-2-nonenal. Cancer Res. 48:1988;320-323.
68. Sodum R.S., Chung F.-L. Stereoselective formation of in vitro nucleic acid adducts by 2,3-epoxy-4-hydroxynonanal. Cancer Res. 51:1991;137-143.
69. 4-ethenocytosine by lipid peroxidation products and nucleic acid bases. Chem. Res. Toxicol. 8:1995;278-283.
70. Nair J., Sone H., Nagao M., Barbin A., Bartsch H. Copper-dependent formation of miscoding etheno-DNA adducts in the liver of Long-Evans cinnamon (LEC) rats developing hereditary hepatitis and hepatocellular carcinoma. Cancer Res. 56:1996;1267-1271.
71. Nair J., Carmichael P.L., Fernando R.C., Philipps D.H., Strain A.J., Bartsch H. Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson's disease and primary hemochromatosis. Cancer Epidemiol. Biomarkers Prev. 7:1998;435-440.
72. Nair J., Gal A., Tamir S., Tannenbaum S.R., Wogan G.N., Bartsch H. Etheno adducts in spleen DNA of SJL mice stimulated to overproduce nitric oxide. Carcinogenesis. 19:1998;2081-2084.
73. Kadlubar F.F., Anderson K.E., Haussermann S., Lang N.P., Barone G.W., Thompson P.A., MacLeod S.L., Chou M.W., Mikhailova M., Plastaras J., Marnett L.J., Nair J., Velic I., Bartsch H. Comparison of DNA adduct levels associated with oxidative stress in human pancreas. Mutat. Res. 405:1998;125-133.
74. Nair J., Vaca C.E., Velic I., Mutanen M., Valsta L.M., Bartsch H. High dietary ω-6 polyunsaturated fatty acids drastically increase the formation of etheno-DNA base adducts in white blood cells of female subjects. Cancer Epidemiol. Biomarkers Prev. 6:1997;597-601.
75. Barbin A., Laib R.J., Bartsch H. Lack of miscoding properties of 7-(2-oxoethyl)guanine, the major vinyl chloride-DNA adduct. Cancer Res. 45:1985;2440-2444.
76. F. Oesch, S. Adler, R. Rettelbach, G. Doerjer, Repair of etheno DNA adducts by N-glycosylases, in: B. Singer, H. Bartsch (Eds.), The Role of Cyclic Nucleic Acid Adducts in Carcinogenesis and Mutagenesis, Vol. 70, IARC Sci. Publ., IARC, Lyon, 1986, pp. 373-379.
77. 6-ethenoadenine in a DNA fragment. Proc. Natl. Acad. Sci. U.S.A. 88:1991;6839-6842.
78. Oesch F., Weiss C.M., Klein S. Use of oligonucleotides containing ethenoadenine to study the repair of this DNA lesion. Determination of individual and collective repair activities. Arch. Toxicol. 68:1994;358-363.
79. Dosanjh M.K., Chenna A., Kim E., Fraenkel-Conrat H., Samson L., Singer B. All four known cyclic adducts formed in DNA by the vinyl chloride metabolite chloroacetaldehyde are released by a human DNA glycosylase. Proc. Natl. Acad. Sci. U.S.A. 91:1994;1024-1028.
80. 6-ethenoadenine and 3-methyladenine. Proc. Natl. Acad. Sci. U.S.A. 89:1992;9386-9390.
81. 6-ethenoadenine when present in DNA. Nucleic Acids Res. 23:1995;3750-3755.
82. 4-ethenocytosine are excised by separate human DNA glycosylases. Carcinogenesis. 17:1996;155-157.
83. 4-ethenocytosine or 8-oxoguanine. Proc. Natl. Acad. Sci. U.S.A. 94:1997;12869-12874.
84. 4-Ethenocytosine, a highly mutagenic adduct, is a primary substrate for Escherichia coli double-stranded uracil-DNA glycosylase and human mismatch-specific thymine-DNA glycosylase. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8508-8513.
85. 4-ethenocytosine and the G/T mismatch. Proc. Natl. Acad. Sci. U.S.A. 95:1998;13561-13566.
86. Fortini P., Parlanti E., Sidorkina O.M., Laval J., Dogliotti E. The type of DNA glycosylase determines the base excision repair pathway in mammalian cells. J. Biol. Chem. 274:1999;15230-15236.
87. 2,3-ethenoguanine from chloroacetaldehyde-treated DNA by Escherichia coli 3-methyladenine DNA glycosylase II. Proc. Natl. Acad. Sci. U.S.A. 89:1992;9331-9334.
88. Przygodzki R.M., Finkelstein S.D., Keohavong P., Zhu D., Bakker A., Swalsky P.A., Soini Y., Ishak K.G., Bennett W.P. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2. Lab. Invest. 76:1997;153-159.
89. Trivers G.E., Cawley H.L., DeBenedetti V.M., Hollstein M., Marion M.-J., Bennett W.P., Hoover M.L., Prives C.C., Tamburro C.C., Harris C.C. Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride. J. Natl. Cancer Inst. 87:1995;1400-1407.
90. Soini Y., Welsh J.A., Ishak K.G., Bennett W.P. p53 mutations in primary hepatic angiosarcomas not associated with vinyl chloride exposure. Carcinogenesis. 16:1995;2879-2881.
91. Andersson M., Jönsson M., Nielsen L.E., Vyberg M., Visfeldt J., Storm H.H., Wallin H. Mutations in the tumor suppressor gene p53 in human liver cancer induced by α-particles. Cancer Epidemiol. Biomarkers Prev. 4:1995;765-770.
92. Froment O., Boivin S., Barbin A., Bancel B., Trépo C., Marion M.-J. Mutagenesis of ras protooncogenes in rat liver tumors induced by vinyl chloride. Cancer Res. 54:1994;5340-5345.
93. Boivin-Angèle S., Lefrançois L., Froment O., Spiethoff A., Bogdanffy M.S., Wegener K., Wech H., Barbin A., Bancel B., Trépo C., Bartsch H., Swenberg J., Marion M.-J. ras gene mutations in vinyl chloride-induced liver tumors are carcinogen-specific but vary with cell type and species. Int. J. Cancer. 85:2000;223-227.
94. Buchmann A., Bauer-Hofmann R., Mahr J., Drinkwater N.R., Luz A., Schwarz M. Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 88:1991;911-915.
95. Ostermayr R., Suchy B., Rabes H.M. Carcinogen-induced liver tumors of Wistar rats: absence of activated ras genes and of N-ras-C. J. Cancer Res. Clin. Oncol. 117:1991;381-384.
96. Baba M., Yamamoto R., Iishi H., Tatsuta M. Ha-ras mutations in N-nitrosomorpholine-induced lesions and inhibition of hepatocarcinogenesis by antisense sequences in rat liver. Int. J. Cancer. 72:1997;815-820.
97. Barbin A., Froment O., Boivin S., Marion M.-J., Belpoggi F., Maltoni C., Montesano R. p53 gene mutation pattern in rat liver tumors induced by vinyl chloride. Cancer Res. 57:1997;1695-1698.
98. Gomez-Angelats M., Teeguarden J.G., Dragan Y.P., Pitot H.C. Mutational analysis of three tumor suppressor genes in two models of rat hepatocarcinogenesis. Mol. Carcinogen. 25:1999;157-163.
99. Vancutsem P.M., Lazarus P., Williams G.M. Frequent and specific mutations of the rat p53 gene in hepatocarcinomas induced by tamoxifen. Cancer Res. 54:1994;3864-3867.
100. Bowden G.T., Krieg P. Differential gene expression during multistage carcinogenesis. Environ. Health Perspect. 93:1991;51-56.
101. Maronpot R.R., Fox T., Malarkey D.E., Goldsworthy T.L. Mutations in the ras protooncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology. 101:1995;125-156.
102. Stanley L.A. Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumor suppressor genes. Toxicology. 96:1995;173-194.
103. Dragani T.A., Manenti G., Pierotti M.A. Genetics of murine lung tumors. Adv. Cancer Res. 67:1995;83-112.
104. Surh Y.J., Kim S.G., Park K.K., Sohn Y., Lee J.M., Kim N.D., Miller J.A. Chemopreventive effects of 2-(allylthio)pyrazine on hepatic lesion, mutagenesis and tumorigenesis induced by vinyl carbamate or vinyl carbamate epoxide. Carcinogenesis. 19:1998;1263-1267.
105. Nelson M.A., Futscher B.W., Kinsella T., Wymer J., Bowden G.T. Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors. Proc. Natl. Acad. Sci. U.S.A. 89:1992;6398-6402.
106. Watson M.A., Devereux T.R., Malarkey D.E., Anderson M.W., Maronpot R.R. H-ras oncogene mutation spectra in B6C3F1 and C57BL/6 mouse liver tumors provide evidence for TCDD promotion of spontaneous and vinyl-carbamate-initiated liver cells. Carcinogenesis. 16:1995;1705-1710.
107. 1 mouse lung lesions induced by urethane. Jpn. J. Cancer Res. 86:1995;802-810.
108. Massey T.E., Devereux T.R., Maronpot R.R., Foley J.F., Anderson M.W. High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1 (C57BL/6J×BALB/cJ) mice. Carcinogenesis. 16:1995;1065-1069.
109. Wang X., Witschi H. Mutations of the Ki-ras protooncogene in 3-methylcholanthrene and urethane-induced and butylated hydroxytoluene-promoted lung tumors of strain A/J and SWR mice. Cancer Lett. 91:1995;33-39.
110. Horio Y., Chen A., Rice P., Roth J.A., Malkinson A.M., Schrump D.S. Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice. Mol. Carcinogen. 17:1996;217-223.
111. Ichikawa T., Yano Y., Uchida M., Otani S., Hagiwara K., Yano T. The activation of K-ras gene at an early stage of lung tumorigenesis in mice. Cancer Lett. 107:1996;165-170.
112. Cazorla M., Hernandez L., Fernandez P.L., Fabra A., Peinado M.A., Dasenbrock C., Tillmann T., Kamino K., Campo E., Kohler M., Morawieltz G., Cardesa A., Tomatis L., Mohr U. Ki-ras gene mutations and absence of p53 gene mutations in spontaneous and urethane-induced early lung lesions in CBA/J mice. Mol. Carcinogen. 21:1998;251-260.
113. 1-induced mouse lung tumors. Cancer Res. 59:1999;3634-3640.
114. Bartsch H., Nair J., Velic I. Etheno-DNA base adducts as tools in human cancer etiology and chemoprevention. Eur. J. Cancer Prev. 6:1997;529-534.
115. 6-Ethenodeoxyadenosine, a DNA adduct highly mutagenic in mammalian cells. Biochemistry. 35:1996;11487-11492.
116. Simha D., Palejwala V.A., Humayun M.Z. Mechanisms of mutagenesis by exocyclic DNA adducts. Construction and in vitro template characteristics of an oligonucleotide bearing a single site-specific ethenocytosine. Biochemistry. 30:1991;8727-8735.
117. 2,3-ethenoguanosine, is a highly efficient mutagen in transcription. Carcinogenesis. 8:1987;745-747.
118. 2,3-ethenoguanine produces G→A transitions in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 88:1991;9974-9978.
119. 2-ethenoguanine, 5,6,7,9-tetrahydro-9-oxoimidazo-[1,2-α]purine, and 5,6,7,9-tetrahydro-7-hydroxy-9-oxoimidazo[1,2-α]purine. Biochemistry. 37:1998;5184-5193.